您的购物车当前为空
Val-Ala-PAB-MMAE 是一种用于抗体药物偶联(ADC)的缀合物,由 Val-Ala-PAB 可裂解连接子和 具有抗肿瘤作用的微管抑制剂MMAE(Monomethyl Auristatin E)组成。在细胞内被组织蛋白酶 B切割后释放 MMAE,实现靶向药物递送,减少对正常组织的毒性,提高抗癌活性。


为众多的药物研发团队赋能,
让新药发现更简单!
Val-Ala-PAB-MMAE 是一种用于抗体药物偶联(ADC)的缀合物,由 Val-Ala-PAB 可裂解连接子和 具有抗肿瘤作用的微管抑制剂MMAE(Monomethyl Auristatin E)组成。在细胞内被组织蛋白酶 B切割后释放 MMAE,实现靶向药物递送,减少对正常组织的毒性,提高抗癌活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 398 | In Stock | |
| 5 mg | ¥ 1,062 | In Stock | |
| 10 mg | ¥ 1,726 | In Stock | |
| 25 mg | ¥ 3,120 | In Stock | |
| 50 mg | ¥ 4,980 | In Stock |
Val-Ala-PAB-MMAE 相关产品
| 产品描述 | Val-Ala-PAB-MMAE is a drug-linker conjugate for antibody-drug conjugates (ADCs), composed of the Val-Ala-PAB cleavable linker and MMAE, a potent microtubule inhibitor. It is designed to be cleaved by Cathepsin B within cancer cells, releasing MMAE to inhibit tubulin polymerization and induce apoptosis. This mechanism reduces toxicity to normal tissues while enhancing antitumor activity. |
| 分子量 | 1037.33 |
| 分子式 | C55H88N8O11 |
| CAS No. | 1912408-92-4 |
| Smiles | [C@H]([C@H](C(N[C@@H]([C@@H](O)C1=CC=CC=C1)C)=O)C)(OC)[C@]2(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(C(OCC3=CC=C(NC([C@@H](NC([C@H](C(C)C)N)=O)C)=O)C=C3)=O)C)C(C)C)=O)[C@@H](C)C)=O)C)[C@H](CC)C)OC)=O)CCC2)[H] |
| 存储 | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (77.12 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (3.18 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容